Literature DB >> 8557369

Localization of biologically important regions on toxic shock syndrome toxin 1.

D L Murray1, C A Earhart, D T Mitchell, D H Ohlendorf, R P Novick, P M Schlievert.   

Abstract

Toxic shock syndrome toxin 1 (TSST-1) contains a long central alpha helix that forms the base of two grooves on opposite sides of the molecule. Previous studies indicated that residues 132, 135, and 140 along the back of the central alpha helix are important in the biological activities. We made mutations of additional central alpha-helix residues exposed along this groove on the back of TSST-1. The proteins were purified, shown not to have gross alteration in structure, and tested for both superantigenicity and ability to elicit lethal TSS, using the superantigenicity, likely to because of alteration in T-cell receptor binding. Mutants H135A, Q136A, and E132K/ Q136K lost the ability to induce lethal TSS. The mutant Q136A was most increasing because it was superantigenic, yet nonlethal.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557369      PMCID: PMC173772          DOI: 10.1128/iai.64.1.371-374.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Structure of toxic shock syndrome toxin 1.

Authors:  G S Prasad; C A Earhart; D L Murray; R P Novick; P M Schlievert; D H Ohlendorf
Journal:  Biochemistry       Date:  1993-12-21       Impact factor: 3.162

2.  Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1.

Authors:  M L Hoffmann; L M Jablonski; K K Crum; S P Hackett; Y I Chi; C V Stauffacher; D L Stevens; G A Bohach
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

3.  Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor.

Authors:  M Iwasaki; H Igarashi; Y Hinuma; T Yutsudo
Journal:  FEBS Lett       Date:  1993-09-27       Impact factor: 4.124

4.  Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1.

Authors:  J Kim; R G Urban; J L Strominger; D C Wiley
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

5.  Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.

Authors:  P F Bonventre; H Heeg; C Cullen; C J Lian
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

6.  A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C.

Authors:  J A Mollick; G G Miller; J M Musser; R G Cook; D Grossman; R R Rich
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1.

Authors:  D L Murray; G S Prasad; C A Earhart; B A Leonard; B N Kreiswirth; R P Novick; D H Ohlendorf; P M Schlievert
Journal:  J Immunol       Date:  1994-01-01       Impact factor: 5.422

8.  Mutations affecting the activity of toxic shock syndrome toxin-1.

Authors:  R L Deresiewicz; J Woo; M Chan; R W Finberg; D L Kasper
Journal:  Biochemistry       Date:  1994-11-01       Impact factor: 3.162

9.  Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells.

Authors:  G Hedlund; M Dohlsten; C Petersson; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

10.  Crystal structure of the superantigen staphylococcal enterotoxin type A.

Authors:  E M Schad; I Zaitseva; V N Zaitsev; M Dohlsten; T Kalland; P M Schlievert; D H Ohlendorf; L A Svensson
Journal:  EMBO J       Date:  1995-07-17       Impact factor: 11.598

View more
  24 in total

1.  Recombinant Staphylococcus aureus exfoliative toxins are not bacterial superantigens.

Authors:  L R Plano; D M Gutman; M Woischnik; C M Collins
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals.

Authors:  P M Schlievert; L M Jablonski; M Roggiani; I Sadler; S Callantine; D T Mitchell; D H Ohlendorf; G A Bohach
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

3.  Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis.

Authors:  J B Travers; Q A Hamid; D A Norris; C Kuhn; R C Giorno; P M Schlievert; E R Farmer; D Y Leung
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 4.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  Quorum sensing in Staphylococcus aureus biofilms.

Authors:  Jeremy M Yarwood; Douglas J Bartels; Esther M Volper; E Peter Greenberg
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

6.  Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants.

Authors:  M Roggiani; J A Stoehr; B A Leonard; P M Schlievert
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

7.  Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus.

Authors:  J M Yarwood; J K McCormick; P M Schlievert
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

8.  A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1).

Authors:  Laura M Breshears; Patrick M Schlievert; Marnie L Peterson
Journal:  J Biol Chem       Date:  2012-07-25       Impact factor: 5.157

9.  Vaccination against Staphylococcus aureus pneumonia.

Authors:  Adam R Spaulding; Wilmara Salgado-Pabón; Joseph A Merriman; Christopher S Stach; Yinduo Ji; Aaron N Gillman; Marnie L Peterson; Patrick M Schlievert
Journal:  J Infect Dis       Date:  2013-12-19       Impact factor: 5.226

Review 10.  Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome.

Authors:  S Ladhani; C L Joannou; D P Lochrie; R W Evans; S M Poston
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.